CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia

Clinical trial NCT06622694 · RECRUITING

Trial details

NCT number: NCT06622694
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Aplastic Anemia Relapse Refractory CAR T-cell Therapy

Start date: 2025-06-19
Primary completion: 2026-10-07
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.